Inventor · disambiguated record
Stephen Chappell Mitchell
Also filed as: MITCHELL STEPHEN C · MITCHELL STEPHEN CHAPPELL
18 granted patents·4 pending applications·543 citations·filing 1999–2011
96Inventor score
Top patents by PatentIndex Score
22 records- 0199US7485299B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2006·Granted Feb 3, 2009·49 cites·18 claims
- 0298US6329503B1Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 1999·Granted Dec 11, 2001·147 cites·16 claims
- 0396US7053186B2Antibodies immunospecific for STEAP1AGENSYS INC·Filed 2001·Granted May 30, 2006·48 cites·7 claims
- 0495US8414898B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAFAR DANIEL E·Filed 2011·Granted Apr 9, 2013·35 cites·24 claims
- 0594US7928201B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2009·Granted Apr 19, 2011·16 cites·20 claims
- 0694US7642054B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2005·Granted Jan 5, 2010·19 cites·21 claims
- 0794US7611904B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2006·Granted Nov 3, 2009·19 cites·39 claims
- 0894US7166714B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2003·Granted Jan 23, 2007·35 cites·6 claims
- 0994US6887975B2Peptides derived from STEAP1AGENSYS INC·Filed 2001·Granted May 3, 2005·40 cites·8 claims
- 1093US7968307B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2009·Granted Jun 28, 2011·14 cites·22 claims
- 1191US7037667B1Tumor antigen useful in diagnosis and therapy of prostate and colon cancerAGENSYS INC·Filed 2000·Granted May 2, 2006·41 cites·10 claims
- 1288US6833438B1Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 1999·Granted Dec 21, 2004·45 cites·6 claims
- 1386US8053551B2Serpentine transmembrane antigens expressed in human cancers and uses thereforAGENSYS INC·Filed 2003·Granted Nov 8, 2011·7 cites·2 claims
- 1463US6509458B1Gene expressed in prostate cancerAGENSYS INC·Filed 1999·Granted Jan 21, 2003·19 cites·6 claims
- 1561US7981624B2Methods to detect tumors using 20P1F12/TMPRSS2 expressionAGENSYS INC·Filed 2009·Granted Jul 19, 2011·0 cites·3 claims
- 1661US2007134253A1Novel serpentine transmembrane antigens expressed in human cancers and uses thereofAFAR DANIEL E·Filed 2006·Application pending·0 cites
- 1757US2010272742A1Novel serpentine transmembrane antigens expressed in human cancers and uses thereofAFAR DANIEL E·Filed 2010·Application pending·0 cites
- 1856US7432346B2Gene expressed in prostate cancerAGENSYS INC·Filed 2002·Granted Oct 7, 2008·0 cites·8 claims
- 1949US2005239122A1Novel tumor antigen useful in diagnosis and therapy of prostate and colon cancerAFAR DANIEL E·Filed 2005·Application pending·0 cites
- 2044US6652859B1PTANS: testis specific proteins expressed in prostate cancerAGENSYS INC·Filed 1999·Granted Nov 25, 2003·9 cites·6 claims
- 2143US2006275304A1Novel tumor antigen useful in diagnosis and therapy of prostate and colon cancerAGENSYS INC·Filed 2005·Application pending·0 cites
- 2241US7803916B2Gene expressed in prostate cancerAGENSYS INC·Filed 2008·Granted Sep 28, 2010·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Stephen Chappell Mitchell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →